2005
DOI: 10.1002/ajmg.a.30481
|View full text |Cite
|
Sign up to set email alerts
|

Double-layered patella in multiple epiphyseal dysplasia is not exclusive toDTDST mutation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
1
1

Year Published

2006
2006
2019
2019

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 6 publications
0
13
1
1
Order By: Relevance
“…One patient had a double-layered patella. Previous studies have reported that the double-layered patella is specific to DTDST mutations [Superti-Furga et al, 1999;Unger and Hecht, 2001]; however, this patient's family history was consistent with autosomal dominant inheritance, and he was found to have a COL9A2 mutation [Nakashima et al, 2005a]. Sixteen patients showed a positive family history.…”
Section: Resultsmentioning
confidence: 80%
“…One patient had a double-layered patella. Previous studies have reported that the double-layered patella is specific to DTDST mutations [Superti-Furga et al, 1999;Unger and Hecht, 2001]; however, this patient's family history was consistent with autosomal dominant inheritance, and he was found to have a COL9A2 mutation [Nakashima et al, 2005a]. Sixteen patients showed a positive family history.…”
Section: Resultsmentioning
confidence: 80%
“…In humans, mutations in COL9A2 and COL9A3 have been associated with multiple epiphyseal dysplasia (MED, EDM2 and EDM3 for COL9A2 and COL9A3 mutations, respectively), (Bonnemann et al , 1999; Paasilta et al , 1999; Holden et al , 1999; Lohiniva et al , 2000; Fiedler et al , 2002; Nakashima et al , 2005a; Nakashima et al , 2005b; Takahashi et al , 2006). MED is one of the common forms of skeletal dysplasia, characterized by a delay in the appearance of the epiphyses, irregular epiphyseal formation, mild short stature, and early-onset osteoarthiritis (Spranger et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Less than 5% of the mutations that are known to cause dominant MED are located in the COL9A2 gene; this type of MED is defined as EDM2 (Briggs and Chapman 2002, Jakkula et al 2005). The EDM2 mutations are all located at different positions within the donor splice site of intron 3 and result in an in-frame deletion of 12 amino acids from the COL3 domain of the collagen chain (Holden et al 1999, Spayde et al 2000, Fiedler et al 2002, Nakashima et al 2005, Takahashi et al 2006). The COL3 domain has proven to be essential for the binding between collagen IX and MATN3, an extracellular matrix protein in cartilage (Fresquet et al 2007).…”
Section: Discussionmentioning
confidence: 99%